Scilex Holding (SCLX) EPS (Diluted) (2020 - 2026)
Scilex Holding (SCLX) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.61 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.28 |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn | -16.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.28 |
| Dec 31, 2025 | -3,000.91 |
| Sep 30, 2025 | -22,167.70 |
| Jun 30, 2025 | -7,422.25 |
| Mar 31, 2025 | -2,255.08 |
| Dec 31, 2024 | -1.69 |
| Sep 30, 2024 | -1,209.82 |
| Jun 30, 2024 | -10,944.09 |
| Mar 31, 2024 | -8,331.17 |
| Dec 31, 2023 | -5.75 |
| Sep 30, 2023 | -22.07 |
| Jun 30, 2023 | -6.54 |
| Mar 31, 2023 | -7.60 |
| Dec 31, 2022 | -4,663.36 |
| Sep 30, 2022 | 57.12 |
| Jun 30, 2022 | -36.29 |
| Mar 31, 2022 | -2.41 |
| Dec 31, 2021 | -12,362.65 |
| Sep 30, 2021 | -0.57 |
| Jun 30, 2021 | -1.68 |